Precision BioSciences Inc (DTIL)

[MI Dendream]

Good coverage of the Lilly deal here. Lilly seems pretty excited...

"This collaboration with Precision BioSciences represents another milestone in the realization of our vision to create medicines with transformational potential, using new therapeutic modalities such as gene editing to tackle targets and indications which were previously undruggable,” said Andrew Adams, Ph.D., vice president of new therapeutic modalities at Eli Lilly, in a statement Friday.

Lilly and Precision will use the latter’s ARCUS genome editing platform to develop new gene therapies. The technology is based on a natural enzyme called a homing endonuclease that can insert or delete a piece of DNA before shutting itself off using a built-in safety switch. The switch is designed to prevent unwanted, off-target edits elsewhere in the genome.

https://www.fiercebiotech.com/biotech/lilly-precision-biosciences-team-up-duchenne-gene-therapy-135m-deal